A natural substance was accidentally discovered from a plant in Africa to have rapid positive effects on heart conditions in the mid-19th Century. Eventually, it became part of mainstream heart medicine in Germany, but administered only by IV under clinical supervision. This natural heart attack remedy and preventative is currently known as ouabain (wah-bay-in) also known as strophanthin (stroe-fan-thin), which was initially extracted from the African tree Acokanthera ouabaio, leading to the English name version ouabain. Currently, there are many German doctors prescribing ouabain or G-strophanthin, and they want to keep it that way even though it’s natural and can’t be patented as a pharmaceutical drug, which is another reason that little is known of it outside of Germany. Dr. Thomas Cowan, MD, debunks the current official explanation of heart disease by analyzing the inconsistencies and paradoxes of actual heart attack cases compared to the accepted arterial clogging explanation. Dr. Cowan is a holistic MD practicing in San Francisco, California. He states by having his heart patients on ouabain he has not lost any of them to heart attacks. His new understanding of heart disease and subsequent successful use of ouabain is attributed to the German doctor Knut Sroka, MD, who calls ouabain “an outstanding plant drug ignored by academic medicine”.
Bad Medical Advice: How Taking an Aspirin a Day for Reported Health Benefits Could Actually Kill You
A few decades ago, during the 1970s, "an apple a day keeps the doctor away" morphed to "an aspirin a day keeps heart attacks and strokes away." Not only does this not work as a preventative measure for cardiac arrest and strokes, the side effects to the gastrointestinal or GI tract range can be severe. This is not an opinion. Several studies and even the FDA have expressed concerns about this approach for a healthy heart. Aspirin depletes the body of life-saving nutrients, such as potassium, sodium, folic acid, iron, and vitamin C, leading to anemia, depression, diarrhea fatigue, suppression of the immune system, and elevated homocysteine, which is ironically a strong heart disease risk factor. Long-term, daily consumption of aspirin can lead to undetected internal bleeding in the GI tract, eventually causing ulcers or leading to other serious inflammatory gastrointestinal conditions, even Crohn's Disease.
Study: Antioxidants in Virgin Coconut Oil Counteract Environmental Pollutants and Improve Cardiovascular Health
A new study published in Avicenna Journal of Phytomedicine sheds further light on how coconut oil, virgin coconut oil in particular, enhances cardiovascular health, in direct contradiction to the U.S. government claims that coconut oil leads to heart disease. As is to be expected, much of the research published in peer-reviewed journals showing that coconut oil enhances heart health in recent years has been conducted outside the U.S., in tropical cultures where coconuts grow. These countries are finding out for themselves that they have been misled by U.S. policy that condemns their native diets which includes coconuts and coconut oil. This current study conducted in Nigeria looked at the pathogenic role of cadmium (Cd) and its exposure in the induction of dyslipidemia implicated in the development and increasing incidence of cardiovascular diseases, and explored whether polyphenolics isolated from virgin coconut oil (VCO) could prevent Cd-induced dyslipidemia. The researchers concluded: "The co-administration of VCO polyphenol with Cd remarkably restored lipid profile and cardiovascular risk ratios and stabilized antioxidant defense systems comparable to control group. This is the first study presenting that polyphenols isolated from VCO prevent Cd-induced lipid abnormalities and cardiovascular risk ratios by improving antioxidant defense systems."
The least publicized actual side effect of cholesterol-lowering statin drugs that complements the dangerous intended effect of reducing cholesterol is they also block CoQ10 production, which is already waning among those aged 40 and older. That’s the age when people begin getting prescribed statins per the newest statin drug guidelines. The irony is that CoQ10 is vital for good heart health! CoQ10 is on high demand from cells in muscle tissue, and the muscle that works the most without rest is the heart. Instead of supplementing CoQ10 when one reaches the 40 year plus mark, he or she will likely be prescribed statin drugs for life as a preventative against cardiovascular disease and heart attack. As statin drugs decrease one’s already lowered CoQ10 production from aging, the heart can get slowly weaker, leading to congestive heart failure. This is when the heart keeps beating, but it is so weak it isn’t strong enough to maintain blood flow throughout to meet the body's needs. Instead of the pain that accompanies a sudden heart attack, gradually one begins to have less and less energy. Excessive tiredness comes in that may be incorrectly attributed to aging or being out of shape. Exercise only further exposes one’s breathing problems. Distended belly and leg swelling also occur. This can go on for years with increasing disability until there is a total heart failure. The newest guidelines for statins almost require physicians to put patients on statins as a preventative practice for life. As the CoQ10 deficiency worsens from statins, the poor patient goes into a debilitating spiral without any recognition to its true cause.
Another peer-reviewed study was published this month (August 2017) showing dietary virgin coconut oil has beneficial heart-health effects regarding lipid profile, renal status, hepatic antioxidant defense system, and cardiovascular risks. The study was conducted by researchers in Nigeria in the Department of Medical Biochemistry, Faculty of Basic Medical Sciences, at Federal University. The title of the study is: Dietary Supplementation with Virgin Coconut Oil Improves Lipid Profile and Hepatic Antioxidant Status and Has Potential Benefits on Cardiovascular Risk Indices in Normal Rats. This new study and many other previous studies clearly contradict the propaganda espoused by Big Pharma and the U.S. Government dietary advice, which has been waging a war against saturated fats since the 1970s and the McGovern Report that promoted the false hypothesis that saturated fats led to an increase in lipid cholesterol levels and an increased risk for heart disease. This theory, the lipid theory of heart disease, has been shown to be false repeatedly by the published medical literature, yet it still remains the official USDA dietary advice.
The pharmaceutical empire strikes back. After the recent few years of increasing “statin deniers” getting an occasional mainstream media appearance, vested interest parties are coming up with studies to “prove” statins (cholesterol-lowering drugs) are safe. The problem is most folks on the fence, as most are, will be distracted by these studies no matter how biased and without merit they may be. Doctors who know the truth about statins are forced to pick any such statin safety study apart in response in order to straighten out doctors who prescribe statins based on pharmaceutical reps’ presentations and industry biased studies. One such doctor who is outspokenly critical of statin drugs, Scottish General Practitioner (GP) Malcom Kendrick, M.D., recently focused on a Lancet paper that intended to prove side effects from statin drugs were not only greatly exaggerated, but all in the patients' heads. According to the paper, patients were suffering from the “nocebo effect,” due to all the rising information regarding statin side effect symptoms publicly reported. In addition to his analysis of the study and comparisons to other studies, Dr. Kendrick offers his personal and professional experiences of taking patients off statins and watching them recover from torn or ravaged muscles and early onset dementia, among other side effects. Dr. Kendrick’s father, whose side effects had him wheel chair bound until his doctor-son convinced him to quit taking statins is an example he offered. No nocebo effects had them in such terrible shape that was relieved when they got off statins.
Since 2015 there have been a few pharmaceutical companies working on a new cholesterol-lowering drug type as a replacement for the older class of statin drugs, such as Lipitor. Lipitor was the best-selling drug of all time, but its patent expired a few years ago. The new mantra is getting LDL cholesterol levels lower than statin drugs. The drug class of these new cholesterol-lowering drugs is a PCSK9 inhibitor. Of course, this is madness for two reasons: (1) Cholesterol and fats, in general, are not the cause of heart disease; (2) cholesterol is vital for hormone production and nervous system and brain function. The fact is that cholesterol is vitally essential for good health, and lowering cholesterol artificially can and does lead to more immediate health problems, and a lower life expectancy. So why the focus for a new cholesterol-lowering drug? Once again, we follow the money.
There have been numerous studies on lauric acid for various health supporting factors. Did you know that virgin coconut oil is 50 percent or more lauric acid? So whatever healthy attributes lauric acid contains so does coconut oil, and more. And more will be explained later in this article. For now we’ll focus on coconut oil’s major component, lauric acid, and a recent animal study with dramatic results discovered for reducing hypertension (high blood pressure) and oxidative stress.
Magnesium is the fourth most abundant mineral in your body. Researchers have detected more than 3,750 magnesium-binding sites on human proteins giving an indication of its wide-ranging health effects. More than 300 different enzymes also rely on magnesium for proper function. A common estimate is that 50 to 80 percent of Americans are deficient in magnesium, and the health consequences are significant. Magnesium plays an important role in your body's biochemical processes, many of which are crucial for proper metabolic function.
Researchers from Rush University Medical Center in Chicago followed more than 800 heart failure patients for an average of three years. Both their health status and salt intake were analyzed. It turned out that those following a low-sodium diet were 85 percent more likely to die or require hospitalization for heart disease compared to those who didn’t restrict their salt intake. Among those restricting their sodium intake, 42 percent died or were hospitalized for heart problems during the study, compared to 26 percent of those with no salt restrictions.